Biologic Response Modifiers as Adjuncts to Other Therapeutic Modalities

Semin Oncol. 1986 Jun;13(2):144-52.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols*
  • BCG Vaccine / therapeutic use
  • Breast Neoplasms / therapy
  • Clinical Trials as Topic
  • Colonic Neoplasms / therapy
  • Combined Modality Therapy
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Drug Evaluation
  • Humans
  • Interferons / therapeutic use
  • Leukemia / therapy
  • Levamisole / therapeutic use
  • Lung Neoplasms / therapy
  • Lymphoma / therapy
  • Melanoma / therapy
  • Mice
  • Neoplasms / therapy*
  • Poly A-U / therapeutic use
  • Prednisone / therapeutic use
  • Rectal Neoplasms / therapy
  • Vincristine / therapeutic use

Substances

  • Adjuvants, Immunologic
  • BCG Vaccine
  • Poly A-U
  • Levamisole
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Interferons
  • Prednisone

Supplementary concepts

  • CHOP protocol